Title:
METHODS AND FORMULATIONS FOR MODULATING LYN KINASE ACTIVITY AND TREATING RELATED DISORDERS
Document Type and Number:
WIPO Patent Application WO2007024863
Kind Code:
A9
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising the compounds or a pharmaceutically acceptable salts thereof that are useful in modulating lyn kinase activity. In particular, the compounds or a pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder including cardiovascular disease, dyslipidemia, dyslipoproteinemia, a disorder of glucose metabolism, metabolic syndrome (i.e., Syndrome X), a peroxisome proliferator activated receptor-associated disorder, septicemia, a thrombotic disorder, type II diabetes, obesity, pancreatitis, hypertension, renal disease, inflammation, or impotence.
Inventors:
REAUME ANDREW (US)
SAPORITO MICHAEL S (US)
SAPORITO MICHAEL S (US)
Application Number:
PCT/US2006/032788
Publication Date:
April 12, 2007
Filing Date:
August 22, 2006
Export Citation:
Assignee:
MELIOR DISCOVERY INC (US)
REAUME ANDREW (US)
SAPORITO MICHAEL S (US)
REAUME ANDREW (US)
SAPORITO MICHAEL S (US)
International Classes:
A61K31/495; A61P3/04
Download PDF: